Analysis of the Glutathione Cycle in Children With Rett Syndrome
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02360436
Recruitment Status :
(Priorities other studies)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
2 Years to 10 Years (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Children aged 2-10 with genetically confirmed diagnosis of Rett syndrome with MeCP2 mutation
Age between 2 and 10, inclusive
Genetically-confirmed diagnosis of Rett syndrome with MeCP2 mutation
No change in dietary supplements in three months prior to the initial blood draw
No participation in interventional pharmaceutical clinical trials in prior 12 months